Science and references
Expertise demonstrated through scientific publications.
Our experience spans more than 50 publications and competitively funded projects across multiple therapeutic areas. This knowledge strengthens each new study and supports work with further diseases and treatments.
Published experience
Bringing scientific knowledge to every project.
The areas below show direct experience supported by publications and publicly documented research projects.
50+scientific publications
01Oncology and precision medicine
Experience in pancreatic, colorectal, gastric, kidney, lung and blood cancers, and tumour biomarkers.
View publications and projects
Publications
- Digital patient modeling identifies predictive biomarkers of regorafenib response in elderly metastatic colorectal cancerFrontiers in Systems Biology, 2025
- A decision support system based on artificial intelligence and systems biology for the simulation of pancreatic cancer patient statusCPT: Pharmacometrics & Systems Pharmacology, 2023
- The LEGACy study: molecular phenotypes and personalized clinical decision making in gastric cancerBMC Cancer, 2022
- Exploring the synergistic effects of cabozantinib and a PD-1 inhibitor in metastatic renal cell carcinoma with machine learningOncotarget, 2022
- Head-to-head evaluation of brigatinib and alectinib as first-line treatment for ALK-positive NSCLCOncotarget, 2021
- Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemiaScientific Reports, 2020
- Biological relationships between miRNAs used for colorectal cancer screeningJournal of Molecular Biomarkers & Diagnosis, 2018
- Functional, structural and contextual analysis of a BRCA1 variant of uncertain clinical significanceJournal of Cancer Genetics and Biomarkers, 2017
- Potato carboxypeptidase inhibitor is an epidermal growth factor antagonist that inhibits tumor cell growthJournal of Biological Chemistry, 1998
Publicly documented projects
02Neurology, neurodegeneration and mental health
Modelling and analysis in multiple sclerosis, ALS, Alzheimer's disease, brain ageing, ADHD and mental health.
View publications and projects
Publications
Publicly documented projects
03Diabetes, metabolism and kidney disease
Research in type 2 diabetes, diabetic nephropathy, nutrition, microalbuminuria, and cognitive and retinal complications.
View publications and projects
Publications
Publicly documented projects
04Cardiovascular medicine, hepatology and gastroenterology
Experience in heart failure, myocardial injury, cirrhosis, NAFLD, associated kidney function and irritable bowel syndrome.
View publications and projects
Publications
Publicly documented projects
05Immunology, rheumatology and inflammatory diseases
Applications in psoriasis, spondyloarthritis, rheumatoid arthritis, periodontal inflammation and adaptive immunity.
View publications and projects
Publications
Publicly documented projects
06Infectious diseases and vaccines
Research in tuberculosis, malaria, COVID-19, bacterial infections and host-pathogen interactions.
View publications and projects
Publications
Publicly documented projects
07Ophthalmology and sensory disorders
Mechanistic analysis in diabetic macular oedema, macular degeneration, ocular safety and visual disorders.
View publications and projects
Publications
Publicly documented projects
08Reproductive, bone, urological and population health
Work on embryo implantation, osteoporosis, urological health, skin ageing and smoking prevention.
View publications
09Systems biology, data and molecular modelling
Methods spanning real-world data, transcriptomics, biological networks, proteins, biosensors and computational discovery.
View publications
Publications
- The usage of transcriptomics datasets as sources of real-world data for clinical triallingbioRxiv, 2022
- CuBlock: a cross-platform normalization method for gene-expression microarraysBioinformatics, 2021
- Same drug, new purposeEuropean Biopharmaceutical Review, 2015
- Virtual-organism toy-model for systems-biology approaches to medical-target discoveryarXiv, 2014
- Systems biology solutions to the microarray nightmareInnovations in Pharmaceutical Technology, 2013
- Towards a molecular characterization of pathological pathwaysFEBS Letters, 2008
- Artistic representation of the human interactome built with AxPathBuilderNature Chemical Biology cover, 2008
- Classification of protein disulphide-bridge topologiesJournal of Computer-Aided Molecular Design, 2001
- Human A2 pro-carboxypeptidase model: improving homology modeling through secondary-structure predictionJournal of Computer-Aided Molecular Design, 2000
- Corrigendum: mechanisms of antibody-enzymatic reactivation in beta-galactosidase molecular sensorsFEBS Letters, 2000
- Detection of molecular interactions using a peptide-displaying bacteriophage biosensorBiochemical and Biophysical Research Communications, 1999
- Distinct mechanisms of antibody-enzymatic reactivation in beta-galactosidase molecular sensorsFEBS Letters, 1998
- Effects of counter-ions and volume on the simulated dynamics of solvated proteinsProtein Engineering, 1998
- Protein similarities beyond disulphide-bridge topologyJournal of Molecular Biology, 1998
- Statistical analysis of loop geometry in a non-redundant database of proteinsJournal of Molecular Modeling, 1998
Beyond these areas
Published experience opens the way to further therapeutic areas.
We can work with other diseases, treatments and populations. We define the scientific question, incorporate available knowledge and adapt the simulation to each project's therapeutic context, involving clinical specialists where they add value.